Literature DB >> 8786053

Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.

M A Lansang1.   

Abstract

The prevalence of chronic hepatitis B virus (HBV) infection in the Philippines, as indicated by hepatitis B surface antigen (HBsAg) positivity, ranges from 2% to 16.5%, with an average of 12% in a study of rural villagers. Although mother to child transmission is a major route of HBV infection, other routes (particularly child to child transmission) play an important part after the first year of life. In a study assessing the feasibility and effectiveness of incorporating hepatitis B vaccine into the national Expanded Programme on Immunisation, the coverage rate for fully immunised 1 year olds ranged from 80.9-84% and anti-HBs seroconversion rates ranged from 72-88%. In countries where HBV is not endemic, high risk groups include commercial sex workers (CSWs) and intravenous drug users (IVDUs), who generally have higher HBsAg positivity rates than the general population. In countries with a high HBV endemicity, carrier rates may be only slightly higher among CSWs, suggesting that other modes of transmission are more important in those regions. CSWs who are also IVDUs are at even greater risk. If HBV infection is to be controlled, innovative education and screening programmes are needed, together with the mass immunisation of neonates now started in many countries around the world.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786053      PMCID: PMC1398043          DOI: 10.1136/gut.38.suppl_2.s43

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  [A seroepidemiological study on sexually transmitted HBV infection].

Authors:  Q Wu; Z Li; J Fan
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1994-04

2.  Direct measurement of hepatitis B viral antibody and antigen markers in gingival crevicular fluid.

Authors:  J J Pollock; L Andors; A Gulumoglu; P F Ells
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1984-05

3.  [Determinants of the prevalence of hepatitis B viral infection in parenteral drug abusers].

Authors:  A Torrella Ramos; I Hernández Aguado; C Santos Rubio; E Fernández García; M García de la Hera; M J Aviñó Rico
Journal:  Rev Clin Esp       Date:  1993-12       Impact factor: 1.556

4.  Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.

Authors:  S Maayan; E N Shufman; D Engelhard; D Shouval
Journal:  Addiction       Date:  1994-07       Impact factor: 6.526

5.  Seroepidemiology of hepatitis B virus in the Philippines.

Authors:  A L Lingao; E O Domingo; S West; C M Reyes; S Gasmen; G Viterbo; E Tiu; M A Lansang
Journal:  Am J Epidemiol       Date:  1986-03       Impact factor: 4.897

6.  HCV, HIV, HBV and HDV infections in intravenous drug addicts.

Authors:  R C Coppola; P E Manconi; R Piro; M L Di Martino; G Masia
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

7.  Hepatitis B virus markers in prostitutes in Singapore.

Authors:  C L Goh; A Kamarudin; S H Chan; V S Rajan
Journal:  Genitourin Med       Date:  1985-04

8.  Hepatitis B infection among STD clinic patients in Sydney.

Authors:  P J Christopher; E B Crewe; P T Mailer; A M Murphy
Journal:  Aust N Z J Med       Date:  1984-08

9.  Hepatitis B infection in prostitutes.

Authors:  C L Goh; V S Rajan; S H Chan; A Kamarudin
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

10.  Hepatitis B virus profile of hepatocellular carcinoma in the Philippines.

Authors:  A L Lingao; E O Domingo; K Nishioka
Journal:  Cancer       Date:  1981-10-01       Impact factor: 6.860

View more
  7 in total

1.  Detection of HBsAg, HBcAg, and HBV DNA in ovarian tissues from patients with HBV infection.

Authors:  Li-Zhang Chen; Xue-Gong Fan; Jian-Ming Gao
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

2.  HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines.

Authors:  Karen S Batoctoy; Tai-Chung Tseng; Jia-Horng Kao; Fidelis E Quiza; Lamberto H Garcia; Judy Lao-Tan
Journal:  Hepatol Int       Date:  2011-03-19       Impact factor: 6.047

3.  Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii.

Authors:  Naoky C S Tsai; Peter S Holck; Linda L Wong; Aldrich A Ricalde
Journal:  Hepatol Int       Date:  2008-10-15       Impact factor: 6.047

4.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

5.  Sero-epidemiology of hepatitis B among new refugees to Minnesota.

Authors:  Chris Ugwu; Prathibha Varkey; Stephanie Bagniewski; Timothy Lesnick
Journal:  J Immigr Minor Health       Date:  2008-10

6.  The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation.

Authors:  R Zain-Hamid; Z Ismail; S Mahendra Raj; I L Shuaib; S S J Mohsin
Journal:  Malays J Med Sci       Date:  2003-01

7.  Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries.

Authors:  Ching-Chiang Lin; Hsiu-Shu Hsieh; Yu-Jie Huang; Yeou-Lih Huang; Ming-Kun Ku; Hsin-Chia Hung
Journal:  BMC Public Health       Date:  2008-02-07       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.